US Stock MarketDetailed Quotes

VTGN VistaGen Therapeutics

Watchlist
  • 3.1100
  • +0.0300+0.97%
Close Nov 1 16:00 ET
  • 3.1100
  • 0.00000.00%
Post 20:01 ET
84.14MMarket Cap-3344P/E (TTM)

VistaGen Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
Total revenue
-52.54%84K
568.72%1.06M
12.17%197.3K
129.06%411.4K
131.11%277.7K
-42.92%177K
-120.47%-227K
352.19%175.9K
-49.82%179.6K
-349.30%-892.5K
Operating revenue
-52.54%84K
568.72%1.06M
12.17%197.3K
129.06%411.4K
131.11%277.7K
-42.92%177K
-120.47%-227K
352.19%175.9K
-49.82%179.6K
-349.30%-892.5K
Cost of revenue
Gross profit
Operating expense
70.24%12.22M
-42.27%34.09M
-6.92%11.56M
-16.59%8.3M
-57.48%7.06M
-64.27%7.18M
21.34%59.04M
-25.80%12.42M
-8.74%9.95M
26.14%16.6M
Selling and administrative expenses
53.36%4.57M
-4.10%14.06M
33.85%4.12M
21.54%3.76M
-13.37%3.21M
-37.85%2.98M
10.69%14.66M
-31.57%3.08M
-0.83%3.09M
14.93%3.7M
-General and administrative expense
53.36%4.57M
-4.10%14.06M
33.85%4.12M
21.54%3.76M
-13.37%3.21M
-14.69%2.98M
40.30%14.66M
-1.50%3.08M
36.09%3.09M
34.81%3.7M
Research and development costs
82.23%7.65M
-54.88%20.02M
-20.36%7.44M
-33.80%4.54M
-70.14%3.85M
-72.55%4.2M
25.33%44.38M
-23.68%9.34M
-11.90%6.85M
29.77%12.89M
Operating profit
-73.35%-12.13M
44.29%-33.02M
7.19%-11.36M
19.27%-7.88M
61.23%-6.78M
64.61%-7M
-24.65%-59.27M
26.68%-12.24M
7.34%-9.77M
-36.64%-17.49M
Net non-operating interest income expense
1,326.53%1.4M
12,788.46%3.35M
12,315.45%1.53M
28,847.17%1.53M
3,055.74%192.5K
4,800.00%98K
30.00%26K
146.00%12.3K
6.00%5.3K
22.00%6.1K
Non-operating interest income
1,326.53%1.4M
----
----
28,847.17%1.53M
3,055.74%192.5K
1,533.33%98K
----
----
6.00%5.3K
22.00%6.1K
Total other finance cost
----
-12,788.46%-3.35M
----
----
----
----
---26K
----
----
----
Other net income (expense)
312K
Other non- operating income (expenses)
----
--312K
----
----
----
----
----
----
----
----
Income before tax
-55.55%-10.73M
50.44%-29.36M
22.14%-9.52M
34.95%-6.35M
62.32%-6.59M
65.10%-6.9M
-24.04%-59.24M
26.73%-12.23M
7.35%-9.76M
-36.65%-17.48M
Income tax
0
-33.33%4K
200.00%1.5K
0
0
-45.45%3K
76.47%6K
500
0
0
Net income
-55.48%-10.73M
50.44%-29.36M
22.13%-9.52M
34.95%-6.35M
62.32%-6.59M
65.09%-6.9M
-24.05%-59.25M
26.73%-12.23M
7.35%-9.76M
-36.65%-17.48M
Net income continuous Operations
-55.48%-10.73M
50.44%-29.36M
22.13%-9.52M
34.95%-6.35M
62.32%-6.59M
65.09%-6.9M
-24.05%-59.25M
26.73%-12.23M
7.35%-9.76M
-36.65%-17.48M
Minority interest income
Net income attributable to the parent company
-55.48%-10.73M
50.44%-29.36M
22.13%-9.52M
34.95%-6.35M
62.32%-6.59M
65.09%-6.9M
-24.05%-59.25M
26.73%-12.23M
7.35%-9.76M
-36.65%-17.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-55.48%-10.73M
50.44%-29.36M
22.13%-9.52M
34.95%-6.35M
62.32%-6.59M
65.09%-6.9M
-21.64%-59.25M
26.73%-12.23M
9.14%-9.76M
-32.75%-17.48M
Basic earnings per share
62.77%-0.35
82.14%-1.52
79.15%-0.3523
84.51%-0.22
74.02%-0.66
67.25%-0.94
-15.32%-8.51
34.48%-1.69
5.33%-1.42
-20.95%-2.54
Diluted earnings per share
62.77%-0.35
82.14%-1.52
79.15%-0.3523
84.51%-0.22
74.02%-0.66
67.25%-0.94
-15.32%-8.51
34.48%-1.69
5.33%-1.42
-20.95%-2.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022
Total revenue -52.54%84K568.72%1.06M12.17%197.3K129.06%411.4K131.11%277.7K-42.92%177K-120.47%-227K352.19%175.9K-49.82%179.6K-349.30%-892.5K
Operating revenue -52.54%84K568.72%1.06M12.17%197.3K129.06%411.4K131.11%277.7K-42.92%177K-120.47%-227K352.19%175.9K-49.82%179.6K-349.30%-892.5K
Cost of revenue
Gross profit
Operating expense 70.24%12.22M-42.27%34.09M-6.92%11.56M-16.59%8.3M-57.48%7.06M-64.27%7.18M21.34%59.04M-25.80%12.42M-8.74%9.95M26.14%16.6M
Selling and administrative expenses 53.36%4.57M-4.10%14.06M33.85%4.12M21.54%3.76M-13.37%3.21M-37.85%2.98M10.69%14.66M-31.57%3.08M-0.83%3.09M14.93%3.7M
-General and administrative expense 53.36%4.57M-4.10%14.06M33.85%4.12M21.54%3.76M-13.37%3.21M-14.69%2.98M40.30%14.66M-1.50%3.08M36.09%3.09M34.81%3.7M
Research and development costs 82.23%7.65M-54.88%20.02M-20.36%7.44M-33.80%4.54M-70.14%3.85M-72.55%4.2M25.33%44.38M-23.68%9.34M-11.90%6.85M29.77%12.89M
Operating profit -73.35%-12.13M44.29%-33.02M7.19%-11.36M19.27%-7.88M61.23%-6.78M64.61%-7M-24.65%-59.27M26.68%-12.24M7.34%-9.77M-36.64%-17.49M
Net non-operating interest income expense 1,326.53%1.4M12,788.46%3.35M12,315.45%1.53M28,847.17%1.53M3,055.74%192.5K4,800.00%98K30.00%26K146.00%12.3K6.00%5.3K22.00%6.1K
Non-operating interest income 1,326.53%1.4M--------28,847.17%1.53M3,055.74%192.5K1,533.33%98K--------6.00%5.3K22.00%6.1K
Total other finance cost -----12,788.46%-3.35M-------------------26K------------
Other net income (expense) 312K
Other non- operating income (expenses) ------312K--------------------------------
Income before tax -55.55%-10.73M50.44%-29.36M22.14%-9.52M34.95%-6.35M62.32%-6.59M65.10%-6.9M-24.04%-59.24M26.73%-12.23M7.35%-9.76M-36.65%-17.48M
Income tax 0-33.33%4K200.00%1.5K00-45.45%3K76.47%6K50000
Net income -55.48%-10.73M50.44%-29.36M22.13%-9.52M34.95%-6.35M62.32%-6.59M65.09%-6.9M-24.05%-59.25M26.73%-12.23M7.35%-9.76M-36.65%-17.48M
Net income continuous Operations -55.48%-10.73M50.44%-29.36M22.13%-9.52M34.95%-6.35M62.32%-6.59M65.09%-6.9M-24.05%-59.25M26.73%-12.23M7.35%-9.76M-36.65%-17.48M
Minority interest income
Net income attributable to the parent company -55.48%-10.73M50.44%-29.36M22.13%-9.52M34.95%-6.35M62.32%-6.59M65.09%-6.9M-24.05%-59.25M26.73%-12.23M7.35%-9.76M-36.65%-17.48M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -55.48%-10.73M50.44%-29.36M22.13%-9.52M34.95%-6.35M62.32%-6.59M65.09%-6.9M-21.64%-59.25M26.73%-12.23M9.14%-9.76M-32.75%-17.48M
Basic earnings per share 62.77%-0.3582.14%-1.5279.15%-0.352384.51%-0.2274.02%-0.6667.25%-0.94-15.32%-8.5134.48%-1.695.33%-1.42-20.95%-2.54
Diluted earnings per share 62.77%-0.3582.14%-1.5279.15%-0.352384.51%-0.2274.02%-0.6667.25%-0.94-15.32%-8.5134.48%-1.695.33%-1.42-20.95%-2.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data